- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03677700
Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC) (FLAVIC)
Study Overview
Detailed Description
After surgery by vitrectomy or preindentation, an anti-inflammatory treatment is conventionally prescribed for a duration of 1 month. However, frequently, during the post-operative control at one month, there may be signs of ocular inflammation or symptoms of discomfort justifying the prolongation of post-operative treatment. A 2012 study evaluated post-operative flare follow-up in 22 vitrectomized patients for retinal detachment, and showed a significantly higher flare 3 months after surgery, compared to the other eye and pre-surgery value.
In this study, the investigators wish to study postoperative inflammation in patients operated for posterior segment ocular surgery (vitrectomy or preindentation) measured by laser flashmeter on a follow-up of one year.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Dalal ASRI
- Phone Number: +33 299284289
- Email: dalal.asri@chu-rennes.fr
Study Contact Backup
- Name: Coralie DOUDNIKOFF
- Email: coralie.doudnikoff@chu-rennes.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Major patient,
- Operation of vitrectomy or preindentation in the ophthalmology department of Rennes University Hospital for one of the following reasons:
- Retinal detachment, rhegmatogenous or not
- Combined surgery
- Membrane peeling
- Macular hole
- Optically targeted vitrectomy (Terson's syndrome, intravitreous haemorrhage)
- Covered by a health insurance system,
- Having received information on the protocol and not having expressed opposition to participating in the study
Exclusion Criteria:
- Vitrectomy for endophthalmitis or posterior uveitis,
- Patient with vitreoretinal proliferation (grade B and C),
- Pregnant or nursing woman,
- Major patient subject to legal protection (safeguard of justice, guardianship, guardianship), person deprived of liberty.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of the flare value
Time Frame: Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
|
Evolution of the flare value preoperatively and then to D7, M1, M2, M3, M6, M12 of the operated eye
|
Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flare values of the fellow eye and the operated eye
Time Frame: Difference between flare values of the fellow eye and the operated eye at each evaluation time : baseline (preoperatively), day 7, month 1, month 2, month 3, month 6, and month 12
|
Flare value of the fellow eye and the operated eye at each evaluation time
|
Difference between flare values of the fellow eye and the operated eye at each evaluation time : baseline (preoperatively), day 7, month 1, month 2, month 3, month 6, and month 12
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flare value of the operated eye
Time Frame: Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
|
Flare value of the operated eye preoperatively and at each evaluation time
|
Changes between baseline (preoperatively) and day 7, month 1, month 2, month 3, month 6, and month 12 measures
|
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
|
Identification of criteria associated with high inflammation : indication of surgery
|
Baseline (preoperatively)
|
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
|
Identification of criteria associated with high inflammation : ophthalmologic antecedents
|
Baseline (preoperatively)
|
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
|
Identification of criteria associated with high inflammation : high preoperative IOP
|
Baseline (preoperatively)
|
Criteria associated with high inflammation
Time Frame: Baseline (preoperatively)
|
Identification of criteria associated with high inflammation : BCVA (better visual acuity corrected) preoperatively
|
Baseline (preoperatively)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dalal ASRI, Rennes University Hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35RC18_3043_FLAVIC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation Eye
-
University College, LondonNational Institute for Health Research, United KingdomCompletedEye Diseases | Eye Infections | Eye InflammationUnited Kingdom
-
Adapt Produtos Oftalmológicos Ltda.UnknownEye Infection/Inflammation OtherBrazil
-
iDrop, Inc.CompletedInflammation EyeUnited States
-
Arcispedale Santa Maria Nuova-IRCCSCompleted
-
Eximore Ltd.Active, not recruitingOcular Inflammation | Dry Eye | Keratoconjunctivitis SiccaMexico
-
Second Affiliated Hospital, School of Medicine,...Active, not recruiting
-
University of TriesteCompleted
-
University of Alabama at BirminghamAllergan Sales, LLCCompleted
-
Federal University of São PauloAllerganCompletedOcular Infection and InflammationBrazil
-
EMSCompletedOcular Inflammation | CataractBrazil
Clinical Trials on Laser Flare Meter
-
University of UtahNational Cancer Institute (NCI)Completed
-
University of UtahAmerican Cancer Society, Inc.Active, not recruitingMelanoma | ChildUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedBreast CancerUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
Central Hospital, Nancy, FranceCompleted
-
Mayo ClinicPfizerCompletedRheumatoid ArthritisUnited States
-
The University of Texas Health Science Center,...Smart Meter CorporationRecruitingType2 Diabetes | Gestational Diabetes | Pregnancy in DiabeticUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
Holland Bloorview Kids Rehabilitation HospitalCompletedAutism Spectrum DisorderCanada